posted on 2019-04-24, 00:00authored byHyunsoo Kim, Heebum Song, Jun-Gyu Park, Dong-Sup Lee, Seung Bum Park
A series of α-GalCer analogues
containing an α-fluorocarbonyl
moiety at the terminal position of the acyl chain were designed for
targeting polar residues in the hydrophobic cavity of CD1d using a
structure-based approach. The acyl chain length was efficiently adjusted
by an asymmetric alkyne–alkyne cross coupling strategy, and
the newly synthesized α-GalCer analogues showed the high Th2-selective
activity of iNKT cells. The biased activity of ligands could be caused
by the hydrogen-bonding interaction between ligands and CD1d according
to the Th2-selective cytokine secretion and molecular docking studies.